The mainstay of treatment in primary<unk>  is based on life style modifications. Most of the time in high risk patients and people with past history of osteoporotic fracture, medical therapy is necessary. Bisphosphonates are the first line treatment for<unk> . Raloxifene is the second line treatment of<unk>  in postmenopausal women, for both treatment and prevention. Denosumab is a human monoclonal antibody designed to inhibit RANKL (RANK ligand), a protein that acts as the primary signal for bone removal. It is used to treat<unk>  in older men and postmenopausal women. Teriparatide and Abaloparatide are human recombinant parathyroid hormones used to treat postmenopausal<unk>  in women with high risk of fracture or to increase bone mass in men with<unk> .
Osteoporosis medical therapy
Osteoarthritis medical therapy
Vitamin D deficiency medical therapy
Osteomyelitis medical therapy
Osteoporosis life style modification
Back pain medical therapy
Hyperparathyroidism medical therapy
Spinal stenosis medical therapy